Khajuria RK, Munschauer M, Ulirsch JC, et al. Ribosome Levels Selectively Regulate Translation and Lineage Commitment in Human Hematopoiesis. Cell. 2018 Mar 22;173(1):90-103.e19. Epub 2018 Mar 15.
Keshishian H, Burgess MW, Specht H, et al. Quantitative, multiplexed workflow for deep analysis of human blood plasma and biomarker discovery by mass spectrometry. Nat Protoc. 2017 Aug;12(8):1683-1701. Epub 2017 Jul 27.
Keshishian H, Addona T, Burgess M, et al. Quantification of cardiovascular biomarkers in patient plasma by targeted mass spectrometry and stable isotope dilution. Mol Cell Proteomics. 2009 Oct;8(10):2339-49. Epub 2009 Jul 13.
Hasmik Keshishian, Ph.D.
Hasmik Keshishian is a senior research scientist in the Proteomics Platform at the Broad Institute of MIT and Harvard working under the direction of Steve Carr. Keshishian’s focus over the past 14 years at the Broad Institute has been the development and application of targeted mass spectrometry technologies for quantifying peptides, proteins, and post translational modifications such as phosphorylation in biological fluids, cells, and tissues. Her research has also been focused on developing new technologies for discovery proteomics in plasma, cells, and tissues.
Recently, Keshishian has developed workflows to achieve detection and quantitation of nearly 5,000 proteins in plasma and to greatly increase throughput of data generation and analysis. In addition, she works on large and small collaborations within and outside of the Broad Institute, helping address biological problems using proteomics tools.
Keshishian holds a Ph.D. in biochemistry and has been trained in mass spectrometry and proteomics.
Contact Hasmik Keshishian via email at email@example.com.